Skip to main content
Erschienen in: Osteoporosis International 3/2015

01.03.2015 | Original Article

Effect of estrogen deficiency on the fixation of titanium implants in chronic kidney disease mice

verfasst von: S. Zhang, Y. Guo, H. Zou, N. Sun, D. Zhao, W. Liu, Y. Dong, G. Cheng, Q. Yuan

Erschienen in: Osteoporosis International | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Summary

We established a chronic kidney disease (CKD) mouse model with estrogen deficiency and inserted titanium implants into the femur of such mice to investigate the fixation of the implants. Both the histomorphometry and implant resistance indicated that estrogen deficiency impaired the fixation of titanium implants inserted into such mice.

Introduction

CKD has been regarded as a worldwide public health problem. Estrogen is a critical factor for both renal protection and bone remodeling. A previous study demonstrated that CKD impairs the early healing of titanium implants. However, the combined effect of estrogen deficiency and CKD on the fixation of titanium implants is largely unknown.

Methods

Forty 9-week-old female C57BL mice were randomly divided into sham, ovariectomy (OVX), CKD, and CKD + OVX groups. Uremia and estrogen deficiency were induced by 5/6 nephrectomy and OVX, respectively. Experimental titanium implants were inserted into the distal end of the femur. Bone-implant contact (BIC) ratio and bone volume (BV/TV) around the implants were histomorphometrically analyzed. The fixation strength of the implant was measured by a biomechanical push-in resistance test.

Results

Serum measurement confirmed a significant increase in serum blood urea nitrogen (BUN) in the CKD group, which was further increased by OVX. Estrogen deficiency led to significant decreases in the BIC ratio, BV/TV, and the push-in resistance in CKD animals. There was a significant interaction between the effects of OVX and CKD, with OVX exacerbating the effects of CKD on BIC ratio and push-in resistance.

Conclusions

The results indicated that estrogen deficiency exerts a synergistic effect with CKD and further impairs the fixation of titanium implants in CKD mice.
Literatur
1.
Zurück zum Zitat Zhang L, Wang F, Wang L et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379:815–822CrossRefPubMed Zhang L, Wang F, Wang L et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379:815–822CrossRefPubMed
2.
Zurück zum Zitat Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS (2007) Prevalence of chronic kidney disease in the United States. JAMA J Am Med Assoc 298:2038–2047CrossRef Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS (2007) Prevalence of chronic kidney disease in the United States. JAMA J Am Med Assoc 298:2038–2047CrossRef
3.
Zurück zum Zitat Kimura G (2007) Predicted prevalence in Japan of chronic kidney disease (CKD). Clin Exp Nephrol 11:188–189CrossRefPubMed Kimura G (2007) Predicted prevalence in Japan of chronic kidney disease (CKD). Clin Exp Nephrol 11:188–189CrossRefPubMed
4.
Zurück zum Zitat Gal-Moscovici A, Sprague SM (2007) Bone health in chronic kidney disease-mineral and bone disease. Adv Chronic Kidney Dis 14:27–36CrossRefPubMed Gal-Moscovici A, Sprague SM (2007) Bone health in chronic kidney disease-mineral and bone disease. Adv Chronic Kidney Dis 14:27–36CrossRefPubMed
5.
Zurück zum Zitat Moe S, Drueke T, Cunningham J et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945–1953CrossRefPubMed Moe S, Drueke T, Cunningham J et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945–1953CrossRefPubMed
6.
Zurück zum Zitat Lee MM, Chu EY, El-Abbadi MM, Foster BL, Tompkins KA, Giachelli CM, Somerman MJ (2010) Characterization of mandibular bone in a mouse model of chronic kidney disease. J Periodontol 81:300–309CrossRefPubMedCentralPubMed Lee MM, Chu EY, El-Abbadi MM, Foster BL, Tompkins KA, Giachelli CM, Somerman MJ (2010) Characterization of mandibular bone in a mouse model of chronic kidney disease. J Periodontol 81:300–309CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Zou H, Zhao X, Sun N et al (2013) Effect of chronic kidney disease on the healing of titanium implants. Bone 56:410–415CrossRefPubMed Zou H, Zhao X, Sun N et al (2013) Effect of chronic kidney disease on the healing of titanium implants. Bone 56:410–415CrossRefPubMed
8.
Zurück zum Zitat Neugarten J (2002) Gender and the progression of renal disease. J Am Soc Nephrol JASN 13:2807–2809CrossRef Neugarten J (2002) Gender and the progression of renal disease. J Am Soc Nephrol JASN 13:2807–2809CrossRef
9.
Zurück zum Zitat Diamond JR, Karnovsky MJ (1988) Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 33:917–924CrossRefPubMed Diamond JR, Karnovsky MJ (1988) Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 33:917–924CrossRefPubMed
10.
Zurück zum Zitat Kummer S, von Gersdorff G, Kemper MJ, Oh J (2012) The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease. Pediatr Nephrol 27:1213–1219CrossRefPubMed Kummer S, von Gersdorff G, Kemper MJ, Oh J (2012) The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease. Pediatr Nephrol 27:1213–1219CrossRefPubMed
11.
Zurück zum Zitat Gross ML, Adamczak M, Rabe T, Harbi NA, Krtil J, Koch A, Hamar P, Amann K, Ritz E (2004) Beneficial effects of estrogens on indices of renal damage in uninephrectomized SHRsp rats. J Am Soc Nephrol JASN 15:348–358CrossRef Gross ML, Adamczak M, Rabe T, Harbi NA, Krtil J, Koch A, Hamar P, Amann K, Ritz E (2004) Beneficial effects of estrogens on indices of renal damage in uninephrectomized SHRsp rats. J Am Soc Nephrol JASN 15:348–358CrossRef
12.
Zurück zum Zitat Hutchens MP, Fujiyoshi T, Komers R, Herson PS, Anderson S (2012) Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo. Am J Physiol Renal Physiol 303:F377–F385CrossRefPubMedCentralPubMed Hutchens MP, Fujiyoshi T, Komers R, Herson PS, Anderson S (2012) Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo. Am J Physiol Renal Physiol 303:F377–F385CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat Berg UB (2006) Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. Nephrol Dial Transplant Off Public Euro Dial Transplant Assoc Euro Renal Assoc 21:2577–2582 Berg UB (2006) Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. Nephrol Dial Transplant Off Public Euro Dial Transplant Assoc Euro Renal Assoc 21:2577–2582
14.
Zurück zum Zitat Manolagas SC, Bellido T, Jilka RL (1995) Sex steroids, cytokines and the bone marrow: new concepts on the pathogenesis of osteoporosis. Ciba Found Sympos 191:187–196, discussion 197-202 Manolagas SC, Bellido T, Jilka RL (1995) Sex steroids, cytokines and the bone marrow: new concepts on the pathogenesis of osteoporosis. Ciba Found Sympos 191:187–196, discussion 197-202
15.
Zurück zum Zitat Eastell R (2005) Role of oestrogen in the regulation of bone turnover at the menarche. J Endocrinol 185:223–234CrossRefPubMed Eastell R (2005) Role of oestrogen in the regulation of bone turnover at the menarche. J Endocrinol 185:223–234CrossRefPubMed
17.
Zurück zum Zitat Richelson LS, Wahner HW, Melton LJ 3rd, Riggs BL (1984) Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med 311:1273–1275CrossRefPubMed Richelson LS, Wahner HW, Melton LJ 3rd, Riggs BL (1984) Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med 311:1273–1275CrossRefPubMed
18.
Zurück zum Zitat Riggs BL (2002) Endocrine causes of age-related bone loss and osteoporosis. Novartis Found Symp 242:247–259, discussion 260-244CrossRefPubMed Riggs BL (2002) Endocrine causes of age-related bone loss and osteoporosis. Novartis Found Symp 242:247–259, discussion 260-244CrossRefPubMed
19.
Zurück zum Zitat Tateishi H, Okamoto Y, Kinoshita K, Hibi H, Ueda M (2013) Effects of implant surface on bone healing around titanium screw implants in ovariectomized rats. Int J Oral Maxillofacial Imp 28:e252–e259CrossRef Tateishi H, Okamoto Y, Kinoshita K, Hibi H, Ueda M (2013) Effects of implant surface on bone healing around titanium screw implants in ovariectomized rats. Int J Oral Maxillofacial Imp 28:e252–e259CrossRef
20.
Zurück zum Zitat de Deco CP, da Silva Marchini AM, Barbara MA, de Vasconcellos LM, da Rocha RF, Marchini L (2011) Negative effects of alcohol intake and estrogen deficiency combination on osseointegration in a rat model. J Oral Implantol 37:633–639CrossRefPubMed de Deco CP, da Silva Marchini AM, Barbara MA, de Vasconcellos LM, da Rocha RF, Marchini L (2011) Negative effects of alcohol intake and estrogen deficiency combination on osseointegration in a rat model. J Oral Implantol 37:633–639CrossRefPubMed
21.
Zurück zum Zitat Giro G, Coelho PG, Pereira RM, Jorgetti V, Marcantonio E Jr, Orrico SR (2011) The effect of oestrogen and alendronate therapies on postmenopausal bone loss around osseointegrated titanium implants. Clin Oral Impl Res 22:259–264CrossRef Giro G, Coelho PG, Pereira RM, Jorgetti V, Marcantonio E Jr, Orrico SR (2011) The effect of oestrogen and alendronate therapies on postmenopausal bone loss around osseointegrated titanium implants. Clin Oral Impl Res 22:259–264CrossRef
22.
Zurück zum Zitat Giro G, Goncalves D, Sakakura CE, Pereira RM, Marcantonio Junior E, Orrico SR (2008) Influence of estrogen deficiency and its treatment with alendronate and estrogen on bone density around osseointegrated implants: radiographic study in female rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontics 105:162–167CrossRef Giro G, Goncalves D, Sakakura CE, Pereira RM, Marcantonio Junior E, Orrico SR (2008) Influence of estrogen deficiency and its treatment with alendronate and estrogen on bone density around osseointegrated implants: radiographic study in female rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontics 105:162–167CrossRef
23.
Zurück zum Zitat Duarte PM, Goncalves PF, Casati MZ, Sallum EA, Nociti FH Jr (2005) Age-related and surgically induced estrogen deficiencies may differently affect bone around titanium implants in rats. J Periodontol 76:1496–1501CrossRefPubMed Duarte PM, Goncalves PF, Casati MZ, Sallum EA, Nociti FH Jr (2005) Age-related and surgically induced estrogen deficiencies may differently affect bone around titanium implants in rats. J Periodontol 76:1496–1501CrossRefPubMed
24.
Zurück zum Zitat Weisinger JR, Gonzalez L, Alvarez H, Hernandez E, Carlini RG, Capriles F, Cervino M, Martinis R, Paz-Martinez V, Bellorin-Font E (2000) Role of persistent amenorrhea in bone mineral metabolism of young hemodialyzed women. Kidney Int 58:331–335CrossRefPubMed Weisinger JR, Gonzalez L, Alvarez H, Hernandez E, Carlini RG, Capriles F, Cervino M, Martinis R, Paz-Martinez V, Bellorin-Font E (2000) Role of persistent amenorrhea in bone mineral metabolism of young hemodialyzed women. Kidney Int 58:331–335CrossRefPubMed
25.
Zurück zum Zitat Barreto FC, Barreto DV, Moyses RM, Neves CL, Jorgetti V, Draibe SA, Canziani ME, Carvalho AB (2006) Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem. Kidney Int 69:1852–1857CrossRefPubMed Barreto FC, Barreto DV, Moyses RM, Neves CL, Jorgetti V, Draibe SA, Canziani ME, Carvalho AB (2006) Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem. Kidney Int 69:1852–1857CrossRefPubMed
26.
Zurück zum Zitat Naves Diaz M, Rodriguez Rodriguez A, Fernandez Martin JL, Serrano Arias M, Menendez Rodriguez P, Cannata Andia JB (2007) Effects of estradiol, calcitriol and both treatments combined on bone histomorphometry in rats with chronic kidney disease and ovariectomy. Bone 41:614–619CrossRefPubMed Naves Diaz M, Rodriguez Rodriguez A, Fernandez Martin JL, Serrano Arias M, Menendez Rodriguez P, Cannata Andia JB (2007) Effects of estradiol, calcitriol and both treatments combined on bone histomorphometry in rats with chronic kidney disease and ovariectomy. Bone 41:614–619CrossRefPubMed
27.
Zurück zum Zitat Gagnon RF, Gallimore B (1988) Characterization of a mouse model of chronic uremia. Urol Res 16:119–126CrossRefPubMed Gagnon RF, Gallimore B (1988) Characterization of a mouse model of chronic uremia. Urol Res 16:119–126CrossRefPubMed
28.
Zurück zum Zitat Lasota A, Danowska-Klonowska D (2004) Experimental osteoporosis—different methods of ovariectomy in female white rats. Rocz Akad Med Bialymst 49(Suppl 1):129–131PubMed Lasota A, Danowska-Klonowska D (2004) Experimental osteoporosis—different methods of ovariectomy in female white rats. Rocz Akad Med Bialymst 49(Suppl 1):129–131PubMed
29.
Zurück zum Zitat Golde WT, Gollobin P, Rodriguez LL (2005) A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab Animal 34:39–43CrossRefPubMed Golde WT, Gollobin P, Rodriguez LL (2005) A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab Animal 34:39–43CrossRefPubMed
30.
Zurück zum Zitat Gava AL, Freitas FP, Meyrelles SS, Silva IV, Graceli JB (2011) Gender-dependent effects of aging on the kidney. Brazilian Journal of Medical and Biological Research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica [et al.] 44:905–913 Gava AL, Freitas FP, Meyrelles SS, Silva IV, Graceli JB (2011) Gender-dependent effects of aging on the kidney. Brazilian Journal of Medical and Biological Research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica [et al.] 44:905–913
31.
Zurück zum Zitat Gluhovschi G, Gluhovschi A, Anastasiu D, Petrica L, Gluhovschi C, Velciov S (2012) Chronic kidney disease and the involvement of estrogen hormones in its pathogenesis and progression. Roman J Int Med Rev Roumaine de Med Int 50:135–144 Gluhovschi G, Gluhovschi A, Anastasiu D, Petrica L, Gluhovschi C, Velciov S (2012) Chronic kidney disease and the involvement of estrogen hormones in its pathogenesis and progression. Roman J Int Med Rev Roumaine de Med Int 50:135–144
32.
Zurück zum Zitat Neugarten J, Acharya A, Silbiger SR (2000) Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol JASN 1:319–329 Neugarten J, Acharya A, Silbiger SR (2000) Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol JASN 1:319–329
33.
Zurück zum Zitat Fung MM, Poddar S, Bettencourt R, Jassal SK, Barrett-Connor E (2011) A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo study. Menopause 18:629–637CrossRefPubMedCentralPubMed Fung MM, Poddar S, Bettencourt R, Jassal SK, Barrett-Connor E (2011) A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo study. Menopause 18:629–637CrossRefPubMedCentralPubMed
34.
Zurück zum Zitat Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D, Sadiq S, Lankireddy S, Kane RL, Wilt TJ (2012) Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 156:570–581CrossRefPubMed Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D, Sadiq S, Lankireddy S, Kane RL, Wilt TJ (2012) Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 156:570–581CrossRefPubMed
35.
Zurück zum Zitat Matuszkiewicz-Rowinska J (2010) KDIGO clinical practice guidelines for the diagnosis, evaluation, prevention, and treatment of mineral and bone disorders in chronic kidney disease. Pol Arch Med Wewn 120:300–306PubMed Matuszkiewicz-Rowinska J (2010) KDIGO clinical practice guidelines for the diagnosis, evaluation, prevention, and treatment of mineral and bone disorders in chronic kidney disease. Pol Arch Med Wewn 120:300–306PubMed
36.
Zurück zum Zitat Manolagas SC (2010) From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 31:266–300CrossRefPubMedCentralPubMed Manolagas SC (2010) From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 31:266–300CrossRefPubMedCentralPubMed
37.
Zurück zum Zitat Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279–302CrossRefPubMed Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279–302CrossRefPubMed
38.
Zurück zum Zitat Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115–137PubMed Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115–137PubMed
40.
Zurück zum Zitat Hernandez E, Valera R, Alonzo E, Bajares-Lilue M, Carlini R, Capriles F, Martinis R, Bellorin-Font E, Weisinger JR (2003) Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis. Kidney Int 63:2269–2274CrossRefPubMed Hernandez E, Valera R, Alonzo E, Bajares-Lilue M, Carlini R, Capriles F, Martinis R, Bellorin-Font E, Weisinger JR (2003) Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis. Kidney Int 63:2269–2274CrossRefPubMed
41.
Zurück zum Zitat Heilberg IP, Hernandez E, Alonzo E, Valera R, Ferreira LG, Gomes SA, Bellorin-Font E, Weisinger JR (2005) Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis. Ren Fail 27:155–161PubMed Heilberg IP, Hernandez E, Alonzo E, Valera R, Ferreira LG, Gomes SA, Bellorin-Font E, Weisinger JR (2005) Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis. Ren Fail 27:155–161PubMed
42.
Zurück zum Zitat Eriguchi R, Umakoshi J, Miura S, Sato Y (2009) Raloxifene ameliorates progressive bone loss in postmenopausal dialysis patients with controlled parathyroid hormone levels. Clin Nephrol 72:423–429CrossRefPubMed Eriguchi R, Umakoshi J, Miura S, Sato Y (2009) Raloxifene ameliorates progressive bone loss in postmenopausal dialysis patients with controlled parathyroid hormone levels. Clin Nephrol 72:423–429CrossRefPubMed
Metadaten
Titel
Effect of estrogen deficiency on the fixation of titanium implants in chronic kidney disease mice
verfasst von
S. Zhang
Y. Guo
H. Zou
N. Sun
D. Zhao
W. Liu
Y. Dong
G. Cheng
Q. Yuan
Publikationsdatum
01.03.2015
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 3/2015
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-014-2952-6

Weitere Artikel der Ausgabe 3/2015

Osteoporosis International 3/2015 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.